nodes	percent_of_prediction	percent_of_DWPC	metapath
Delavirdine—CYP3A7-CYP3A51P—Tretinoin—peripheral nervous system neoplasm	0.0798	0.118	CbGbCtD
Delavirdine—CYP3A7—Tretinoin—peripheral nervous system neoplasm	0.0798	0.118	CbGbCtD
Delavirdine—CYP3A5—Tretinoin—peripheral nervous system neoplasm	0.0599	0.0886	CbGbCtD
Delavirdine—CYP2C8—Tretinoin—peripheral nervous system neoplasm	0.0576	0.0852	CbGbCtD
Delavirdine—CYP1A2—Alitretinoin—peripheral nervous system neoplasm	0.0479	0.0709	CbGbCtD
Delavirdine—CYP2C9—Tretinoin—peripheral nervous system neoplasm	0.0402	0.0594	CbGbCtD
Delavirdine—CYP1A2—Dacarbazine—peripheral nervous system neoplasm	0.0383	0.0567	CbGbCtD
Delavirdine—CYP3A7-CYP3A51P—Vincristine—peripheral nervous system neoplasm	0.0367	0.0542	CbGbCtD
Delavirdine—CYP3A7—Vincristine—peripheral nervous system neoplasm	0.0367	0.0542	CbGbCtD
Delavirdine—CYP3A5—Vincristine—peripheral nervous system neoplasm	0.0275	0.0407	CbGbCtD
Delavirdine—CYP3A5—Etoposide—peripheral nervous system neoplasm	0.0252	0.0373	CbGbCtD
Delavirdine—CYP3A4—Topotecan—peripheral nervous system neoplasm	0.0251	0.0372	CbGbCtD
Delavirdine—CYP2C8—Etoposide—peripheral nervous system neoplasm	0.0242	0.0358	CbGbCtD
Delavirdine—CYP3A4—Tretinoin—peripheral nervous system neoplasm	0.0234	0.0345	CbGbCtD
Delavirdine—CYP1A2—Etoposide—peripheral nervous system neoplasm	0.0188	0.0277	CbGbCtD
Delavirdine—CYP2C9—Cisplatin—peripheral nervous system neoplasm	0.0172	0.0254	CbGbCtD
Delavirdine—CYP3A4—Vincristine—peripheral nervous system neoplasm	0.0107	0.0159	CbGbCtD
Delavirdine—CYP2D6—Doxorubicin—peripheral nervous system neoplasm	0.0105	0.0156	CbGbCtD
Delavirdine—CYP3A4—Etoposide—peripheral nervous system neoplasm	0.00982	0.0145	CbGbCtD
Delavirdine—CYP3A4—Doxorubicin—peripheral nervous system neoplasm	0.0067	0.00991	CbGbCtD
Delavirdine—Skin disorder—Etoposide—peripheral nervous system neoplasm	0.000124	0.000384	CcSEcCtD
Delavirdine—Dry skin—Doxorubicin—peripheral nervous system neoplasm	0.000124	0.000382	CcSEcCtD
Delavirdine—Hyperhidrosis—Etoposide—peripheral nervous system neoplasm	0.000124	0.000382	CcSEcCtD
Delavirdine—Pancreatitis—Epirubicin—peripheral nervous system neoplasm	0.000124	0.000382	CcSEcCtD
Delavirdine—Orthostatic hypotension—Doxorubicin—peripheral nervous system neoplasm	0.000123	0.000381	CcSEcCtD
Delavirdine—Anorexia—Etoposide—peripheral nervous system neoplasm	0.000122	0.000377	CcSEcCtD
Delavirdine—Toxic epidermal necrolysis—Doxorubicin—peripheral nervous system neoplasm	0.000122	0.000375	CcSEcCtD
Delavirdine—Aspartate aminotransferase increased—Doxorubicin—peripheral nervous system neoplasm	0.000122	0.000375	CcSEcCtD
Delavirdine—Decreased appetite—Cisplatin—peripheral nervous system neoplasm	0.000121	0.000375	CcSEcCtD
Delavirdine—Bronchitis—Epirubicin—peripheral nervous system neoplasm	0.000121	0.000375	CcSEcCtD
Delavirdine—Diarrhoea—Dactinomycin—peripheral nervous system neoplasm	0.000121	0.000373	CcSEcCtD
Delavirdine—Hypersensitivity—Alitretinoin—peripheral nervous system neoplasm	0.000121	0.000373	CcSEcCtD
Delavirdine—Gastrointestinal disorder—Cisplatin—peripheral nervous system neoplasm	0.000121	0.000372	CcSEcCtD
Delavirdine—Pancytopenia—Epirubicin—peripheral nervous system neoplasm	0.00012	0.00037	CcSEcCtD
Delavirdine—Hypotension—Etoposide—peripheral nervous system neoplasm	0.00012	0.000369	CcSEcCtD
Delavirdine—Gastritis—Doxorubicin—peripheral nervous system neoplasm	0.00012	0.000369	CcSEcCtD
Delavirdine—Pain—Cisplatin—peripheral nervous system neoplasm	0.00012	0.000369	CcSEcCtD
Delavirdine—Muscular weakness—Doxorubicin—peripheral nervous system neoplasm	0.000119	0.000368	CcSEcCtD
Delavirdine—Neutropenia—Epirubicin—peripheral nervous system neoplasm	0.000118	0.000364	CcSEcCtD
Delavirdine—Asthenia—Alitretinoin—peripheral nervous system neoplasm	0.000118	0.000363	CcSEcCtD
Delavirdine—Abdominal distension—Doxorubicin—peripheral nervous system neoplasm	0.000118	0.000363	CcSEcCtD
Delavirdine—Upper respiratory tract infection—Epirubicin—peripheral nervous system neoplasm	0.000117	0.000362	CcSEcCtD
Delavirdine—Influenza—Doxorubicin—peripheral nervous system neoplasm	0.000117	0.00036	CcSEcCtD
Delavirdine—Dysphagia—Doxorubicin—peripheral nervous system neoplasm	0.000117	0.00036	CcSEcCtD
Delavirdine—Hypersensitivity—Vincristine—peripheral nervous system neoplasm	0.000116	0.000359	CcSEcCtD
Delavirdine—Pruritus—Alitretinoin—peripheral nervous system neoplasm	0.000116	0.000358	CcSEcCtD
Delavirdine—Eosinophilia—Doxorubicin—peripheral nervous system neoplasm	0.000116	0.000357	CcSEcCtD
Delavirdine—Feeling abnormal—Cisplatin—peripheral nervous system neoplasm	0.000115	0.000355	CcSEcCtD
Delavirdine—Paraesthesia—Etoposide—peripheral nervous system neoplasm	0.000115	0.000355	CcSEcCtD
Delavirdine—Weight increased—Epirubicin—peripheral nervous system neoplasm	0.000115	0.000354	CcSEcCtD
Delavirdine—Pancreatitis—Doxorubicin—peripheral nervous system neoplasm	0.000114	0.000353	CcSEcCtD
Delavirdine—Dyspnoea—Etoposide—peripheral nervous system neoplasm	0.000114	0.000352	CcSEcCtD
Delavirdine—Hyperglycaemia—Epirubicin—peripheral nervous system neoplasm	0.000114	0.000351	CcSEcCtD
Delavirdine—Somnolence—Etoposide—peripheral nervous system neoplasm	0.000114	0.000351	CcSEcCtD
Delavirdine—Asthenia—Vincristine—peripheral nervous system neoplasm	0.000113	0.00035	CcSEcCtD
Delavirdine—Pneumonia—Epirubicin—peripheral nervous system neoplasm	0.000113	0.000349	CcSEcCtD
Delavirdine—Vomiting—Dactinomycin—peripheral nervous system neoplasm	0.000112	0.000347	CcSEcCtD
Delavirdine—Bronchitis—Doxorubicin—peripheral nervous system neoplasm	0.000112	0.000347	CcSEcCtD
Delavirdine—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	0.000112	0.000346	CcSEcCtD
Delavirdine—Stevens-Johnson syndrome—Epirubicin—peripheral nervous system neoplasm	0.000112	0.000344	CcSEcCtD
Delavirdine—Rash—Dactinomycin—peripheral nervous system neoplasm	0.000112	0.000344	CcSEcCtD
Delavirdine—Decreased appetite—Etoposide—peripheral nervous system neoplasm	0.000111	0.000343	CcSEcCtD
Delavirdine—Pancytopenia—Doxorubicin—peripheral nervous system neoplasm	0.000111	0.000342	CcSEcCtD
Delavirdine—Gastrointestinal disorder—Etoposide—peripheral nervous system neoplasm	0.000111	0.000341	CcSEcCtD
Delavirdine—Body temperature increased—Cisplatin—peripheral nervous system neoplasm	0.00011	0.000341	CcSEcCtD
Delavirdine—Fatigue—Etoposide—peripheral nervous system neoplasm	0.00011	0.000341	CcSEcCtD
Delavirdine—Neuropathy peripheral—Epirubicin—peripheral nervous system neoplasm	0.00011	0.00034	CcSEcCtD
Delavirdine—Jaundice—Epirubicin—peripheral nervous system neoplasm	0.00011	0.000338	CcSEcCtD
Delavirdine—Stomatitis—Epirubicin—peripheral nervous system neoplasm	0.00011	0.000338	CcSEcCtD
Delavirdine—Pain—Etoposide—peripheral nervous system neoplasm	0.000109	0.000338	CcSEcCtD
Delavirdine—Constipation—Etoposide—peripheral nervous system neoplasm	0.000109	0.000338	CcSEcCtD
Delavirdine—Urinary tract infection—Epirubicin—peripheral nervous system neoplasm	0.000109	0.000338	CcSEcCtD
Delavirdine—Conjunctivitis—Epirubicin—peripheral nervous system neoplasm	0.000109	0.000338	CcSEcCtD
Delavirdine—Neutropenia—Doxorubicin—peripheral nervous system neoplasm	0.000109	0.000337	CcSEcCtD
Delavirdine—Upper respiratory tract infection—Doxorubicin—peripheral nervous system neoplasm	0.000109	0.000335	CcSEcCtD
Delavirdine—Dizziness—Alitretinoin—peripheral nervous system neoplasm	0.000108	0.000335	CcSEcCtD
Delavirdine—Diarrhoea—Vincristine—peripheral nervous system neoplasm	0.000108	0.000334	CcSEcCtD
Delavirdine—Haematuria—Epirubicin—peripheral nervous system neoplasm	0.000107	0.000331	CcSEcCtD
Delavirdine—Weight increased—Doxorubicin—peripheral nervous system neoplasm	0.000106	0.000328	CcSEcCtD
Delavirdine—Epistaxis—Epirubicin—peripheral nervous system neoplasm	0.000106	0.000328	CcSEcCtD
Delavirdine—Sinusitis—Epirubicin—peripheral nervous system neoplasm	0.000106	0.000326	CcSEcCtD
Delavirdine—Feeling abnormal—Etoposide—peripheral nervous system neoplasm	0.000106	0.000326	CcSEcCtD
Delavirdine—Hyperglycaemia—Doxorubicin—peripheral nervous system neoplasm	0.000105	0.000325	CcSEcCtD
Delavirdine—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.000105	0.000324	CcSEcCtD
Delavirdine—Pneumonia—Doxorubicin—peripheral nervous system neoplasm	0.000105	0.000323	CcSEcCtD
Delavirdine—Gastrointestinal pain—Etoposide—peripheral nervous system neoplasm	0.000105	0.000323	CcSEcCtD
Delavirdine—Dizziness—Vincristine—peripheral nervous system neoplasm	0.000105	0.000323	CcSEcCtD
Delavirdine—Vomiting—Alitretinoin—peripheral nervous system neoplasm	0.000104	0.000322	CcSEcCtD
Delavirdine—Rash—Alitretinoin—peripheral nervous system neoplasm	0.000103	0.000319	CcSEcCtD
Delavirdine—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	0.000103	0.000319	CcSEcCtD
Delavirdine—Stevens-Johnson syndrome—Doxorubicin—peripheral nervous system neoplasm	0.000103	0.000319	CcSEcCtD
Delavirdine—Hypersensitivity—Cisplatin—peripheral nervous system neoplasm	0.000103	0.000318	CcSEcCtD
Delavirdine—Bradycardia—Epirubicin—peripheral nervous system neoplasm	0.000103	0.000317	CcSEcCtD
Delavirdine—Headache—Alitretinoin—peripheral nervous system neoplasm	0.000103	0.000317	CcSEcCtD
Delavirdine—Neuropathy peripheral—Doxorubicin—peripheral nervous system neoplasm	0.000102	0.000315	CcSEcCtD
Delavirdine—Urticaria—Etoposide—peripheral nervous system neoplasm	0.000102	0.000314	CcSEcCtD
Delavirdine—Stomatitis—Doxorubicin—peripheral nervous system neoplasm	0.000101	0.000313	CcSEcCtD
Delavirdine—Jaundice—Doxorubicin—peripheral nervous system neoplasm	0.000101	0.000313	CcSEcCtD
Delavirdine—Rhinitis—Epirubicin—peripheral nervous system neoplasm	0.000101	0.000312	CcSEcCtD
Delavirdine—Body temperature increased—Etoposide—peripheral nervous system neoplasm	0.000101	0.000312	CcSEcCtD
Delavirdine—Abdominal pain—Etoposide—peripheral nervous system neoplasm	0.000101	0.000312	CcSEcCtD
Delavirdine—Urinary tract infection—Doxorubicin—peripheral nervous system neoplasm	0.000101	0.000312	CcSEcCtD
Delavirdine—Conjunctivitis—Doxorubicin—peripheral nervous system neoplasm	0.000101	0.000312	CcSEcCtD
Delavirdine—Hepatitis—Epirubicin—peripheral nervous system neoplasm	0.000101	0.000312	CcSEcCtD
Delavirdine—Hypoaesthesia—Epirubicin—peripheral nervous system neoplasm	0.000101	0.00031	CcSEcCtD
Delavirdine—Vomiting—Vincristine—peripheral nervous system neoplasm	0.0001	0.00031	CcSEcCtD
Delavirdine—Asthenia—Cisplatin—peripheral nervous system neoplasm	0.0001	0.000309	CcSEcCtD
Delavirdine—Pharyngitis—Epirubicin—peripheral nervous system neoplasm	0.0001	0.000309	CcSEcCtD
Delavirdine—Rash—Vincristine—peripheral nervous system neoplasm	9.96e-05	0.000308	CcSEcCtD
Delavirdine—Dermatitis—Vincristine—peripheral nervous system neoplasm	9.96e-05	0.000307	CcSEcCtD
Delavirdine—Oedema peripheral—Epirubicin—peripheral nervous system neoplasm	9.95e-05	0.000307	CcSEcCtD
Delavirdine—Haematuria—Doxorubicin—peripheral nervous system neoplasm	9.93e-05	0.000306	CcSEcCtD
Delavirdine—Headache—Vincristine—peripheral nervous system neoplasm	9.9e-05	0.000306	CcSEcCtD
Delavirdine—Epistaxis—Doxorubicin—peripheral nervous system neoplasm	9.82e-05	0.000303	CcSEcCtD
Delavirdine—Sinusitis—Doxorubicin—peripheral nervous system neoplasm	9.77e-05	0.000301	CcSEcCtD
Delavirdine—Nausea—Alitretinoin—peripheral nervous system neoplasm	9.74e-05	0.000301	CcSEcCtD
Delavirdine—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	9.56e-05	0.000295	CcSEcCtD
Delavirdine—Erythema multiforme—Epirubicin—peripheral nervous system neoplasm	9.55e-05	0.000295	CcSEcCtD
Delavirdine—Bradycardia—Doxorubicin—peripheral nervous system neoplasm	9.51e-05	0.000294	CcSEcCtD
Delavirdine—Hypersensitivity—Etoposide—peripheral nervous system neoplasm	9.43e-05	0.000291	CcSEcCtD
Delavirdine—Tinnitus—Epirubicin—peripheral nervous system neoplasm	9.42e-05	0.000291	CcSEcCtD
Delavirdine—Nausea—Vincristine—peripheral nervous system neoplasm	9.39e-05	0.00029	CcSEcCtD
Delavirdine—Rhinitis—Doxorubicin—peripheral nervous system neoplasm	9.37e-05	0.000289	CcSEcCtD
Delavirdine—Hepatitis—Doxorubicin—peripheral nervous system neoplasm	9.35e-05	0.000288	CcSEcCtD
Delavirdine—Hypoaesthesia—Doxorubicin—peripheral nervous system neoplasm	9.3e-05	0.000287	CcSEcCtD
Delavirdine—Pharyngitis—Doxorubicin—peripheral nervous system neoplasm	9.28e-05	0.000286	CcSEcCtD
Delavirdine—Oedema peripheral—Doxorubicin—peripheral nervous system neoplasm	9.21e-05	0.000284	CcSEcCtD
Delavirdine—Asthenia—Etoposide—peripheral nervous system neoplasm	9.19e-05	0.000283	CcSEcCtD
Delavirdine—Chills—Epirubicin—peripheral nervous system neoplasm	9.06e-05	0.00028	CcSEcCtD
Delavirdine—Pruritus—Etoposide—peripheral nervous system neoplasm	9.06e-05	0.00028	CcSEcCtD
Delavirdine—Alopecia—Epirubicin—peripheral nervous system neoplasm	8.93e-05	0.000275	CcSEcCtD
Delavirdine—Vomiting—Cisplatin—peripheral nervous system neoplasm	8.89e-05	0.000274	CcSEcCtD
Delavirdine—Erythema multiforme—Doxorubicin—peripheral nervous system neoplasm	8.84e-05	0.000273	CcSEcCtD
Delavirdine—Rash—Cisplatin—peripheral nervous system neoplasm	8.81e-05	0.000272	CcSEcCtD
Delavirdine—Dermatitis—Cisplatin—peripheral nervous system neoplasm	8.8e-05	0.000272	CcSEcCtD
Delavirdine—Malnutrition—Epirubicin—peripheral nervous system neoplasm	8.79e-05	0.000271	CcSEcCtD
Delavirdine—Erythema—Epirubicin—peripheral nervous system neoplasm	8.79e-05	0.000271	CcSEcCtD
Delavirdine—Diarrhoea—Etoposide—peripheral nervous system neoplasm	8.76e-05	0.00027	CcSEcCtD
Delavirdine—Tinnitus—Doxorubicin—peripheral nervous system neoplasm	8.71e-05	0.000269	CcSEcCtD
Delavirdine—Flatulence—Epirubicin—peripheral nervous system neoplasm	8.66e-05	0.000267	CcSEcCtD
Delavirdine—Tension—Epirubicin—peripheral nervous system neoplasm	8.63e-05	0.000266	CcSEcCtD
Delavirdine—Dysgeusia—Epirubicin—peripheral nervous system neoplasm	8.61e-05	0.000266	CcSEcCtD
Delavirdine—Nervousness—Epirubicin—peripheral nervous system neoplasm	8.54e-05	0.000264	CcSEcCtD
Delavirdine—Back pain—Epirubicin—peripheral nervous system neoplasm	8.51e-05	0.000262	CcSEcCtD
Delavirdine—Dizziness—Etoposide—peripheral nervous system neoplasm	8.47e-05	0.000261	CcSEcCtD
Delavirdine—Muscle spasms—Epirubicin—peripheral nervous system neoplasm	8.45e-05	0.000261	CcSEcCtD
Delavirdine—Chills—Doxorubicin—peripheral nervous system neoplasm	8.39e-05	0.000259	CcSEcCtD
Delavirdine—Nausea—Cisplatin—peripheral nervous system neoplasm	8.3e-05	0.000256	CcSEcCtD
Delavirdine—Vision blurred—Epirubicin—peripheral nervous system neoplasm	8.29e-05	0.000256	CcSEcCtD
Delavirdine—Alopecia—Doxorubicin—peripheral nervous system neoplasm	8.26e-05	0.000255	CcSEcCtD
Delavirdine—Ill-defined disorder—Epirubicin—peripheral nervous system neoplasm	8.16e-05	0.000252	CcSEcCtD
Delavirdine—Vomiting—Etoposide—peripheral nervous system neoplasm	8.14e-05	0.000251	CcSEcCtD
Delavirdine—Erythema—Doxorubicin—peripheral nervous system neoplasm	8.14e-05	0.000251	CcSEcCtD
Delavirdine—Malnutrition—Doxorubicin—peripheral nervous system neoplasm	8.14e-05	0.000251	CcSEcCtD
Delavirdine—Anaemia—Epirubicin—peripheral nervous system neoplasm	8.13e-05	0.000251	CcSEcCtD
Delavirdine—Agitation—Epirubicin—peripheral nervous system neoplasm	8.08e-05	0.000249	CcSEcCtD
Delavirdine—Rash—Etoposide—peripheral nervous system neoplasm	8.07e-05	0.000249	CcSEcCtD
Delavirdine—Dermatitis—Etoposide—peripheral nervous system neoplasm	8.06e-05	0.000249	CcSEcCtD
Delavirdine—Headache—Etoposide—peripheral nervous system neoplasm	8.02e-05	0.000247	CcSEcCtD
Delavirdine—Flatulence—Doxorubicin—peripheral nervous system neoplasm	8.02e-05	0.000247	CcSEcCtD
Delavirdine—Tension—Doxorubicin—peripheral nervous system neoplasm	7.98e-05	0.000246	CcSEcCtD
Delavirdine—Dysgeusia—Doxorubicin—peripheral nervous system neoplasm	7.97e-05	0.000246	CcSEcCtD
Delavirdine—Malaise—Epirubicin—peripheral nervous system neoplasm	7.93e-05	0.000245	CcSEcCtD
Delavirdine—Nervousness—Doxorubicin—peripheral nervous system neoplasm	7.9e-05	0.000244	CcSEcCtD
Delavirdine—Vertigo—Epirubicin—peripheral nervous system neoplasm	7.9e-05	0.000244	CcSEcCtD
Delavirdine—Syncope—Epirubicin—peripheral nervous system neoplasm	7.89e-05	0.000243	CcSEcCtD
Delavirdine—Leukopenia—Epirubicin—peripheral nervous system neoplasm	7.87e-05	0.000243	CcSEcCtD
Delavirdine—Back pain—Doxorubicin—peripheral nervous system neoplasm	7.87e-05	0.000243	CcSEcCtD
Delavirdine—Muscle spasms—Doxorubicin—peripheral nervous system neoplasm	7.82e-05	0.000241	CcSEcCtD
Delavirdine—Palpitations—Epirubicin—peripheral nervous system neoplasm	7.77e-05	0.00024	CcSEcCtD
Delavirdine—Loss of consciousness—Epirubicin—peripheral nervous system neoplasm	7.73e-05	0.000238	CcSEcCtD
Delavirdine—Cough—Epirubicin—peripheral nervous system neoplasm	7.67e-05	0.000237	CcSEcCtD
Delavirdine—Vision blurred—Doxorubicin—peripheral nervous system neoplasm	7.67e-05	0.000237	CcSEcCtD
Delavirdine—Nausea—Etoposide—peripheral nervous system neoplasm	7.6e-05	0.000235	CcSEcCtD
Delavirdine—Hypertension—Epirubicin—peripheral nervous system neoplasm	7.59e-05	0.000234	CcSEcCtD
Delavirdine—Ill-defined disorder—Doxorubicin—peripheral nervous system neoplasm	7.55e-05	0.000233	CcSEcCtD
Delavirdine—Anaemia—Doxorubicin—peripheral nervous system neoplasm	7.52e-05	0.000232	CcSEcCtD
Delavirdine—Chest pain—Epirubicin—peripheral nervous system neoplasm	7.49e-05	0.000231	CcSEcCtD
Delavirdine—Arthralgia—Epirubicin—peripheral nervous system neoplasm	7.49e-05	0.000231	CcSEcCtD
Delavirdine—Myalgia—Epirubicin—peripheral nervous system neoplasm	7.49e-05	0.000231	CcSEcCtD
Delavirdine—Agitation—Doxorubicin—peripheral nervous system neoplasm	7.48e-05	0.000231	CcSEcCtD
Delavirdine—Anxiety—Epirubicin—peripheral nervous system neoplasm	7.46e-05	0.00023	CcSEcCtD
Delavirdine—Discomfort—Epirubicin—peripheral nervous system neoplasm	7.4e-05	0.000228	CcSEcCtD
Delavirdine—Malaise—Doxorubicin—peripheral nervous system neoplasm	7.34e-05	0.000226	CcSEcCtD
Delavirdine—Dry mouth—Epirubicin—peripheral nervous system neoplasm	7.32e-05	0.000226	CcSEcCtD
Delavirdine—Vertigo—Doxorubicin—peripheral nervous system neoplasm	7.31e-05	0.000226	CcSEcCtD
Delavirdine—Syncope—Doxorubicin—peripheral nervous system neoplasm	7.3e-05	0.000225	CcSEcCtD
Delavirdine—Leukopenia—Doxorubicin—peripheral nervous system neoplasm	7.28e-05	0.000225	CcSEcCtD
Delavirdine—Confusional state—Epirubicin—peripheral nervous system neoplasm	7.24e-05	0.000223	CcSEcCtD
Delavirdine—Palpitations—Doxorubicin—peripheral nervous system neoplasm	7.19e-05	0.000222	CcSEcCtD
Delavirdine—Oedema—Epirubicin—peripheral nervous system neoplasm	7.18e-05	0.000221	CcSEcCtD
Delavirdine—Loss of consciousness—Doxorubicin—peripheral nervous system neoplasm	7.15e-05	0.000221	CcSEcCtD
Delavirdine—Infection—Epirubicin—peripheral nervous system neoplasm	7.13e-05	0.00022	CcSEcCtD
Delavirdine—Cough—Doxorubicin—peripheral nervous system neoplasm	7.1e-05	0.000219	CcSEcCtD
Delavirdine—Shock—Epirubicin—peripheral nervous system neoplasm	7.06e-05	0.000218	CcSEcCtD
Delavirdine—Thrombocytopenia—Epirubicin—peripheral nervous system neoplasm	7.03e-05	0.000217	CcSEcCtD
Delavirdine—Hypertension—Doxorubicin—peripheral nervous system neoplasm	7.02e-05	0.000217	CcSEcCtD
Delavirdine—Tachycardia—Epirubicin—peripheral nervous system neoplasm	7e-05	0.000216	CcSEcCtD
Delavirdine—Skin disorder—Epirubicin—peripheral nervous system neoplasm	6.97e-05	0.000215	CcSEcCtD
Delavirdine—Hyperhidrosis—Epirubicin—peripheral nervous system neoplasm	6.94e-05	0.000214	CcSEcCtD
Delavirdine—Chest pain—Doxorubicin—peripheral nervous system neoplasm	6.93e-05	0.000214	CcSEcCtD
Delavirdine—Myalgia—Doxorubicin—peripheral nervous system neoplasm	6.93e-05	0.000214	CcSEcCtD
Delavirdine—Arthralgia—Doxorubicin—peripheral nervous system neoplasm	6.93e-05	0.000214	CcSEcCtD
Delavirdine—Anxiety—Doxorubicin—peripheral nervous system neoplasm	6.9e-05	0.000213	CcSEcCtD
Delavirdine—Discomfort—Doxorubicin—peripheral nervous system neoplasm	6.84e-05	0.000211	CcSEcCtD
Delavirdine—Anorexia—Epirubicin—peripheral nervous system neoplasm	6.84e-05	0.000211	CcSEcCtD
Delavirdine—Dry mouth—Doxorubicin—peripheral nervous system neoplasm	6.77e-05	0.000209	CcSEcCtD
Delavirdine—Hypotension—Epirubicin—peripheral nervous system neoplasm	6.71e-05	0.000207	CcSEcCtD
Delavirdine—Confusional state—Doxorubicin—peripheral nervous system neoplasm	6.7e-05	0.000207	CcSEcCtD
Delavirdine—Oedema—Doxorubicin—peripheral nervous system neoplasm	6.64e-05	0.000205	CcSEcCtD
Delavirdine—Infection—Doxorubicin—peripheral nervous system neoplasm	6.6e-05	0.000204	CcSEcCtD
Delavirdine—Musculoskeletal discomfort—Epirubicin—peripheral nervous system neoplasm	6.54e-05	0.000202	CcSEcCtD
Delavirdine—Shock—Doxorubicin—peripheral nervous system neoplasm	6.53e-05	0.000202	CcSEcCtD
Delavirdine—Thrombocytopenia—Doxorubicin—peripheral nervous system neoplasm	6.5e-05	0.000201	CcSEcCtD
Delavirdine—Insomnia—Epirubicin—peripheral nervous system neoplasm	6.49e-05	0.0002	CcSEcCtD
Delavirdine—Tachycardia—Doxorubicin—peripheral nervous system neoplasm	6.48e-05	0.0002	CcSEcCtD
Delavirdine—Skin disorder—Doxorubicin—peripheral nervous system neoplasm	6.45e-05	0.000199	CcSEcCtD
Delavirdine—Paraesthesia—Epirubicin—peripheral nervous system neoplasm	6.44e-05	0.000199	CcSEcCtD
Delavirdine—Hyperhidrosis—Doxorubicin—peripheral nervous system neoplasm	6.42e-05	0.000198	CcSEcCtD
Delavirdine—Dyspnoea—Epirubicin—peripheral nervous system neoplasm	6.4e-05	0.000197	CcSEcCtD
Delavirdine—Somnolence—Epirubicin—peripheral nervous system neoplasm	6.38e-05	0.000197	CcSEcCtD
Delavirdine—Anorexia—Doxorubicin—peripheral nervous system neoplasm	6.33e-05	0.000195	CcSEcCtD
Delavirdine—Dyspepsia—Epirubicin—peripheral nervous system neoplasm	6.32e-05	0.000195	CcSEcCtD
Delavirdine—Decreased appetite—Epirubicin—peripheral nervous system neoplasm	6.24e-05	0.000193	CcSEcCtD
Delavirdine—Hypotension—Doxorubicin—peripheral nervous system neoplasm	6.2e-05	0.000191	CcSEcCtD
Delavirdine—Gastrointestinal disorder—Epirubicin—peripheral nervous system neoplasm	6.2e-05	0.000191	CcSEcCtD
Delavirdine—Fatigue—Epirubicin—peripheral nervous system neoplasm	6.19e-05	0.000191	CcSEcCtD
Delavirdine—Pain—Epirubicin—peripheral nervous system neoplasm	6.14e-05	0.000189	CcSEcCtD
Delavirdine—Constipation—Epirubicin—peripheral nervous system neoplasm	6.14e-05	0.000189	CcSEcCtD
Delavirdine—Musculoskeletal discomfort—Doxorubicin—peripheral nervous system neoplasm	6.05e-05	0.000187	CcSEcCtD
Delavirdine—Insomnia—Doxorubicin—peripheral nervous system neoplasm	6.01e-05	0.000185	CcSEcCtD
Delavirdine—Paraesthesia—Doxorubicin—peripheral nervous system neoplasm	5.96e-05	0.000184	CcSEcCtD
Delavirdine—Dyspnoea—Doxorubicin—peripheral nervous system neoplasm	5.92e-05	0.000183	CcSEcCtD
Delavirdine—Feeling abnormal—Epirubicin—peripheral nervous system neoplasm	5.91e-05	0.000182	CcSEcCtD
Delavirdine—Somnolence—Doxorubicin—peripheral nervous system neoplasm	5.9e-05	0.000182	CcSEcCtD
Delavirdine—Gastrointestinal pain—Epirubicin—peripheral nervous system neoplasm	5.87e-05	0.000181	CcSEcCtD
Delavirdine—Dyspepsia—Doxorubicin—peripheral nervous system neoplasm	5.85e-05	0.00018	CcSEcCtD
Delavirdine—Decreased appetite—Doxorubicin—peripheral nervous system neoplasm	5.77e-05	0.000178	CcSEcCtD
Delavirdine—Gastrointestinal disorder—Doxorubicin—peripheral nervous system neoplasm	5.73e-05	0.000177	CcSEcCtD
Delavirdine—Fatigue—Doxorubicin—peripheral nervous system neoplasm	5.72e-05	0.000177	CcSEcCtD
Delavirdine—Urticaria—Epirubicin—peripheral nervous system neoplasm	5.7e-05	0.000176	CcSEcCtD
Delavirdine—Pain—Doxorubicin—peripheral nervous system neoplasm	5.68e-05	0.000175	CcSEcCtD
Delavirdine—Constipation—Doxorubicin—peripheral nervous system neoplasm	5.68e-05	0.000175	CcSEcCtD
Delavirdine—Body temperature increased—Epirubicin—peripheral nervous system neoplasm	5.67e-05	0.000175	CcSEcCtD
Delavirdine—Abdominal pain—Epirubicin—peripheral nervous system neoplasm	5.67e-05	0.000175	CcSEcCtD
Delavirdine—Feeling abnormal—Doxorubicin—peripheral nervous system neoplasm	5.47e-05	0.000169	CcSEcCtD
Delavirdine—Gastrointestinal pain—Doxorubicin—peripheral nervous system neoplasm	5.43e-05	0.000168	CcSEcCtD
Delavirdine—Hypersensitivity—Epirubicin—peripheral nervous system neoplasm	5.29e-05	0.000163	CcSEcCtD
Delavirdine—Urticaria—Doxorubicin—peripheral nervous system neoplasm	5.28e-05	0.000163	CcSEcCtD
Delavirdine—Body temperature increased—Doxorubicin—peripheral nervous system neoplasm	5.25e-05	0.000162	CcSEcCtD
Delavirdine—Abdominal pain—Doxorubicin—peripheral nervous system neoplasm	5.25e-05	0.000162	CcSEcCtD
Delavirdine—Asthenia—Epirubicin—peripheral nervous system neoplasm	5.15e-05	0.000159	CcSEcCtD
Delavirdine—Pruritus—Epirubicin—peripheral nervous system neoplasm	5.08e-05	0.000157	CcSEcCtD
Delavirdine—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	4.91e-05	0.000152	CcSEcCtD
Delavirdine—Hypersensitivity—Doxorubicin—peripheral nervous system neoplasm	4.89e-05	0.000151	CcSEcCtD
Delavirdine—Asthenia—Doxorubicin—peripheral nervous system neoplasm	4.76e-05	0.000147	CcSEcCtD
Delavirdine—Dizziness—Epirubicin—peripheral nervous system neoplasm	4.75e-05	0.000146	CcSEcCtD
Delavirdine—Pruritus—Doxorubicin—peripheral nervous system neoplasm	4.7e-05	0.000145	CcSEcCtD
Delavirdine—Vomiting—Epirubicin—peripheral nervous system neoplasm	4.56e-05	0.000141	CcSEcCtD
Delavirdine—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	4.54e-05	0.00014	CcSEcCtD
Delavirdine—Rash—Epirubicin—peripheral nervous system neoplasm	4.52e-05	0.00014	CcSEcCtD
Delavirdine—Dermatitis—Epirubicin—peripheral nervous system neoplasm	4.52e-05	0.00014	CcSEcCtD
Delavirdine—Headache—Epirubicin—peripheral nervous system neoplasm	4.5e-05	0.000139	CcSEcCtD
Delavirdine—Dizziness—Doxorubicin—peripheral nervous system neoplasm	4.39e-05	0.000136	CcSEcCtD
Delavirdine—Nausea—Epirubicin—peripheral nervous system neoplasm	4.26e-05	0.000132	CcSEcCtD
Delavirdine—Vomiting—Doxorubicin—peripheral nervous system neoplasm	4.22e-05	0.00013	CcSEcCtD
Delavirdine—Rash—Doxorubicin—peripheral nervous system neoplasm	4.19e-05	0.000129	CcSEcCtD
Delavirdine—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	4.18e-05	0.000129	CcSEcCtD
Delavirdine—Headache—Doxorubicin—peripheral nervous system neoplasm	4.16e-05	0.000128	CcSEcCtD
Delavirdine—Nausea—Doxorubicin—peripheral nervous system neoplasm	3.94e-05	0.000122	CcSEcCtD
